http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009166200-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afa4cfdf55cc8cae190f45ccb59c657c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b906686108d2492803f53ae0a630faa9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf2d1f5fe445e875fabf43668e323a36 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N27-44747 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N27-26 |
| filingDate | 2008-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a070f1698ea19eaa55355a08565bdc9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_835fa734f09d77723dd12b691b8408b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5622742094710304fbe9fbe4df7013f2 |
| publicationDate | 2009-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2009166200-A1 |
| titleOfInvention | Serum components that bind to threat agents |
| abstract | Low molecular weight serum components (less than 10,000 m.w.), in vaccinated animals and a human subject who has been exposed to a threat agent inadvertently, bound to purified O-polysaccharide (OPS, a polymer of formamido-mannose) and a candidate of a threat agent, such as Brucella suis 145 vaccine is disclosed. These components formed a loose reversible precipitin with OPS in a high-salt borate-buffered agarose gel and bound to the candidate vaccine as observed by capillary electrophoresis. By using modified capillary electrophoresis, the invention also discloses the presence of two larger serum components, one similar in size to that of serum albumin and one resembles that of mannan-binding lectin, that bound to the vaccine. An indirect method for identifying vaccination is the presence of antibodies against Brucella -OPS-antibodies. ELISA, capillary electrophoresis and animal challenge studies showed that as high as 30% of the control animals did not require vaccination. These animals could have been exposed to cross-reactive cross-protective antigens naturally. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103278635-A |
| priorityDate | 2007-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 142.